Managers
Innovia Medical (Innovia), Shore Capital Partners’ specialty surgical products platform, has acquired with Eagle Laboratories (Eagle Labs), a manufacturer and distributor of ophthalmic products, focusing on single-use cannula, micro-surgical knives, and blades.
“Since their founding over 28 years ago, Eagle Labs has established themselves as a best-in-class supplier of ophthalmic cannula, knives, and blades, becoming a trusted partner and market leader in the industry. We are impressed with what the De Camp family and their team have accomplished and are excited to partner with them in the next stage of growth,” says Terry Meredith, Chief Executive Officer of Innovia.
High Road Capital Partners’ portfolio company U-C Coatings has completed the acquisition of Contechem. The deal marks High Road’s 50th transaction.
The two companies provide complementary products for protecting freshly cut lumber and logs. Based in Portland, Oregon, Contechem is a leading manufacturer of wood protection products. Contechem’s Britewood anti-stain products inhibit mould growth and discoloration on wood and lumber, and the company’s proprietary application technology and equipment reduce waste and enhance worker safety.
“Joining Contechem’s innovative sapstain products with U-C Coatings’ industry-leading wood sealants and end paints provides an ideal cross-selling opportunity and one-stop shop package to customers,”
An affiliate of HIG Capital has completed the acquisition of Reliant Rehabilitation Holdings, a provider of therapy services to skilled nursing facilities.
Headquartered in Plano, TX, Reliant is one of the largest providers of contract therapy services in the United States. The Company utilises a proprietary care model that emphasises early intervention/assessment, properly designed clinical care plans and pathways to improve patients’ functional levels. Reliant differentiates itself by possessing best-in-class therapist recruitment, program performance management, customer marketing support and industry-leading compliance systems.
Chris Bird, Chief Executive Officer of Reliant, says: “We’re excited to partner with HIG for the next
David Hall of the Philipp Family Office, Mark Stephens of Blackstar Capital and Morgan Metters, previously of Kimura Capital, have joined forces to create Blackstar Asset Management, a UK based investment advisor.
With Swiss family office seed capital, the firm will focus on sustainable private debt strategies such as direct loans, deal participation and niche private fund opportunities.
The new firm will benefit from the established deal origination and structuring capacity of the experienced Blackstar Trade Finance team, and the wider Blackstar Group will benefit from increased funding sources.
“We are extremely excited about this new partnership,” says
An affiliate of private equity firm HIG Capital has completed a strategic investment in Assistência Multidisciplinar em Oncologia (AMO), an independent oncology clinic in Brazil and a nationally recognised provider of cancer treatment.
Headquartered in Salvador, and with eight clinics in the State of Bahia, AMO is the largest oncological service provider in the State, offering comprehensive cancer treatments to patients in partnership with a large clinical team and several local hospitals. With recognised quality and patient-centric care, the Company is among a selected group of seven organisations outside the US with a distinguished quality certification from the American Society
Mid-market private equity investor LDC has completed the sale of fume extraction and filtration specialist BOFA International (BOFA) to NYSE-listed Donaldson Company, a worldwide manufacturer of filtration systems and parts.
Donaldson has agreed to acquire an 88 per cent stake in BOFA for GBP79 million, valuing the business at GBP90 million.
BOFA specialises in the design, development and manufacture of fume and dust extraction systems across a range of applications and sectors including laser, electronics, mechanical engineering, printing and 3D printing, pharmaceutical and dental. Its clients include world leading companies such as such as ASM Pacific Technology, Videojet Technologies,
Private equity firm MidOcean Partners has acquired Florida Food Products (FFP), a manufacturer of natural and clean label ingredients, from Kainos Capital. MidOcean’s investment will be used to drive FFP’s continued growth and expansion.
Financial terms of the transaction have not been disclosed.
Founded in 1954 and headquartered in Eustis, Florida, FFP is a leading manufacturer of healthy, natural, clean label ingredients and is the market leader in the clean label cure market. Clean label cures are used for a wide variety of end market uses including packaged meat, foodservice, private label and branded CPG meats as well as
Atlantic-Pacific Capital has held the final closing of Dalmore Capital 3 (DCF 3) at its hardcap with GBP950 million of capital commitments. DCF 3 received support from a diverse group of new and existing investors across the UK, Germany and Asia.
The offering attracted a wide range of institutional investors, including public and corporate pension funds, insurance groups and investment management groups.
Dalmore Capital Limited (Dalmore Capital) is an independent fund management company that seeks to provide institutional investors with access to low volatility infrastructure assets, particularly in the UK. As such, the Fund’s core investment strategy chiefly
Seasalt, the Cornish lifestyle and clothing brand, has secured a GBP16 million investment in the company to support future growth and development in the business. The investment will see BGF invest GBP11.5 million, with Santander Corporate & Commercial providing an additional GBP4.5 million in funding.
In the last three years, Seasalt’s turnover has grown from GBP28 million to GBP51 million. The company now employs 869 people and is one of the largest private employers in Cornwall. In March, Seasalt opened its 50th store in the UK, bucking the recent prevailing trend on the British high street.
With this new
Ancor Capital Partners, a Dallas-based private equity firm, has acquired STATinMED Research, a medical technology company in the health economics and outcomes research (HEOR) industry.
The transaction, which was finalised on 7 September, represents Ancor’s largest acquisition to date. Terms of the transaction have not been disclosed.
As one of the world’s leading HEOR companies, STATinMED is transforming the way health care uses real world data to accelerate research and generate evidence that provides enhanced decision-making capabilities for the market. Using their customised research methodologies and a diverse set of data sources, STATinMED draws on millions of data points
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
